National Pharmacy Health & Leadership Alliance Verify a MemberMember Login

NPHLA Daily

NPHLA Daily

Wednesday, November 18, 2026 · 4-minute read

Good morning. Here is what changed across metabolic medicine, pharmacy regulation, aesthetics and healthcare technology since yesterday — every item linked to its source.

What changed today in Metabolic: 3 trial updates, 3 new studies

NPHLA tracked 6 new official records on this desk today: 3 trial updates, 3 new studies. First: New trial registered: FORTIFY (Fighting Osteoporosis With Risedronate Co-Therapy During Incretin)

What changed today in Metabolic: 1 new study

NPHLA tracked 1 new official record on this desk today: 1 new study. First: New research in Current gastroenterology reports: “Nutrition in the Era of Incretin-Based Therapies: Clinical Strategies for Optimizing Care”.

What changed today in Regulatory: 1 proposed rule

NPHLA tracked 1 new official record on this desk today: 1 proposed rule. First: Proposed rule published: Rulemaking To Provide That N-acetyl-L-cysteine Is Not Excluded From the Dietary Supplement Definition.

What changed today in Aesthetics & Longevity: 1 trial update, 1 recall record

NPHLA tracked 2 new official records on this desk today: 1 trial update, 1 recall record. First: Trial status changed to “Recruiting”: AWAKENING (Phase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia)

Comments close: Compounding Animal Drugs From Bulk Drug Substances: Compounding Under CGMP in Federally-Registered Facilities; Draft Guidance for Industry; Availability; Agency Information…

November 26, 2026 — verified from the Federal Register comments_close_on.

5 things to know

  1. What changed today in Metabolic: 3 trial updates, 3 new studies
  2. What changed today in Aesthetics & Longevity: 1 trial update, 1 recall record
  3. What changed today in Metabolic: 1 new study
  4. What changed today in Regulatory: 1 proposed rule
  5. Trial status changed to “Recruiting”: AWAKENING (Phase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia) (ClinicalTrials.gov (U.S. National Library of Medicine))

Compiled by NPHLA Intelligence from published briefings and official records. Professional information only — not medical or legal advice. Our standards.